Send to

Choose Destination
Toxicol Ind Health. 1992 Sep-Oct;8(5):267-71.

A study of the carcinogenicity of glycidol in Syrian hamsters.

Author information

ABL-Basic Research Program, Frederick Cancer Research and Development Facility, Maryland.


The industrial chemical glycidol is a directly acting mutagen and a broadly acting carcinogen in rats. It was administered to Syrian golden hamsters (20 male and 20 female) by gavage of 12 mg twice a week for 60 weeks. The total dose per animal was 1.45 g or 20 mmol. Survival was not different from control hamsters treated with corn oil/ethyl acetate. Of the treated males, 9 had tumors and 13 of the treated females had tumors, some of which were adrenal cortex tumors seen in controls. More tumors were seen in the glycidol-treated hamsters than in controls, but the spleen was the only notable target organ and the number of animals with spleen hemangiosarcomas was small. Glycidol appeared to be less carcinogenic in hamsters than in rats or mice.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center